BlueBird Bio has purchased a 125,000-square foot facility in Durham, North Carolina, that it will use for manufacturing the lentiviral vectors used in its gene therapies
from Forbes Real Time https://www.forbes.com/sites/matthewherper/2017/11/29/a-virus-shortage-bluebird-bio-buys-a-factory-to-make-its-own/
via IFTTT
No comments:
Post a Comment